|
DSCR3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.09070530385225E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.89559956409857E-10 |
| Normal-vs-Stage2 |
3.46570000031576E-07 |
| Normal-vs-Stage3 |
1.37799993638055E-10 |
| Normal-vs-Stage4 |
4.27439994510337E-09 |
| Stage1-vs-Stage2 |
8.627200E-01 |
| Stage1-vs-Stage3 |
2.790800E-01 |
| Stage1-vs-Stage4 |
3.661400E-01 |
| Stage2-vs-Stage3 |
5.661200E-01 |
| Stage2-vs-Stage4 |
5.658200E-01 |
| Stage3-vs-Stage4 |
9.406600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.18747242541895E-12 |
| Normal-vs-AfricanAmerican |
1.495750E-03 |
| Normal-vs-Asian |
1.07820000039283E-07 |
| Caucasian-vs-AfricanAmerican |
1.074230E-01 |
| Caucasian-vs-Asian |
9.259000E-01 |
| AfricanAmerican-vs-Asian |
1.898190E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.42388356450374E-12 |
| Normal-vs-Female |
2.00079952605847E-10 |
| Male-vs-Female |
5.015700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.03069999599381E-09 |
| Normal-vs-Age(41-60Yrs) |
4.68847183299204E-13 |
| Normal-vs-Age(61-80Yrs) |
2.53029996954979E-09 |
| Normal-vs-Age(81-100Yrs) |
6.630800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.080000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.803000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.280200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.981800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.132600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.290600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.285600E-01 |
| Classical-VS-Follicular |
7.102000E-01 |
| Classical-VS-Other |
4.408100E-02 |
| Classical-VS-Normal |
5.05699926378611E-11 |
| Tall-VS-Follicular |
9.559400E-01 |
| Tall-VS-Other |
7.699900E-02 |
| Tall-VS-Normal |
3.24299999998612E-06 |
| Follicular-VS-Other |
1.481360E-01 |
| Follicular-VS-Normal |
4.7220999999098E-08 |
| Other-VS-Normal |
2.06020000004248E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.57079912913127E-11 |
| Normal-vs-N1 |
8.39860403445414E-11 |
| N0-vs-N1 |
7.705600E-02 |
|
|
